Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: ticagrelor

« Back to Dashboard
Ticagrelor is the generic ingredient in one branded drug marketed by Astrazeneca Lp and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has two hundred and five patent family members in forty-two countries.

There are eight drug master file entries for ticagrelor. Three suppliers are listed for this compound.

Summary for Generic Name: ticagrelor

Tradenames:1
Patents:5
Applicants:1
NDAs:1
Drug Master File Entries: see list8
Suppliers: see list3

Clinical Trials for: ticagrelor

High Ticagrelor Loading Dose in STEMI
Status: Completed Condition: Coronary Artery Disease

Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients
Status: Recruiting Condition: Coronary Artery Disease

Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis
Status: Recruiting Condition: End Stage Renal Disease; Vascular Access Patency

Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
Status: Recruiting Condition: Coronary Artery Disease; Acute Coronary Syndrome

Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome
Status: Not yet recruiting Condition: Acute Coronary Syndrome

OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study)
Status: Completed Condition: ST Elevation Myocardial Infarction

In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
Status: Recruiting Condition: Coronary Artery Disease

Cangrelor Ticagrelor Transition Study
Status: Completed Condition: Coronary Artery Disease

Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis
Status: Not yet recruiting Condition: Acute ST Segment Elevation Myocardial Infarction; Acute Coronary Syndrome

Reversal of the Anti-platelet Effects of Ticagrelor
Status: Not yet recruiting Condition: Coronary Artery Disease

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
You have an error in your SQL syntax; check the manual that corresponds to your MySQL server version for the right syntax to use near 'LIMIT 5' at line 4